Group One Trading
ACET icon

Group One Trading’s Adicet Bio ACET Stock Holding History

Group One Trading’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$681 Buy
+100
New +$749 ﹤0.01% 7277
2025
Q2 		– Sell
-56
Closed -$680 – 7853
2025
Q1 		$680 Sell
56
-882
-94% -$12.6K ﹤0.01% 7238
2024
Q4 		$14.4K Buy
938
+563
+150% +$10.6K ﹤0.01% 5905
2024
Q3 		$8.64K Buy
+375
New +$8.39K ﹤0.01% 5664
2024
Q2 		– Sell
-31
Closed -$1.18K – 6616
2024
Q1 		$1.18K Sell
31
-532
-94% -$22K ﹤0.01% 6602
2023
Q4 		$17K Hold
563
– – ﹤0.01% 5868
2023
Q3 		$12.3K Buy
+563
New +$19.9K ﹤0.01% 6222
2020
Q3 		– Sell
-13
Closed -$3K – 6014
2020
Q2 		$3K Hold
13
– – ﹤0.01% 5470
2020
Q1 		$2K Buy
+13
New +$1.93K ﹤0.01% 4943

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Group One Trading's ACET Position: Q2 2025 in Review

Group One Trading sold out of Adicet Bio (ACET) in Q2 2025, closing a stake of 425 shares — an estimated $4.48K sold.

Group One Trading first reported a position in ACET in Q4 2019 and held it in 10 quarters. The position peaked at $219K in Q2 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q2 2025.

  • Group One Trading reported no remaining Adicet Bio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 425 Adicet Bio shares in Q2 2025, an estimated $4.48K.
  • Group One Trading first reported a position in Adicet Bio in Q4 2019 and held it in 10 quarters.
  • Group One Trading's Adicet Bio position peaked at $219K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.